OWL | Ophthalmic Innovation | Advancing Diversity in Leadership

OWL Membership

Learn More

Partner With Us

Learn More

Upcoming Events

Learn More
“Let’s Keep in Touch”

Sign up for access to exclusive content, events, materials and updates from OWL.

Why Join OWL?

Vision

OWL’s vision is to promote and develop diverse leadership to advance ophthalmic innovation and patient care.

Mission

OWL works across Eyecare. Our mission is to provide professional and personal development and create opportunities for collaboration.

Rarely will you find a value as great as an OWL membership! By becoming a member you establish yourself as committed to "Advancing Diversity in Leadership" and in standing as a leader for today's world. You'll also be affiliated with the best and brightest in Ophthalmology. Take a look here at some of our Champion members!

LEARN MORE

Blog

Get Involved

Developing leaders is OWL's mission and our specialty!  Get terrific experience and benefit from the best-of-the-best networking in Ophthalmology when you get involved in OWL:

  • Attend an Event
  • Submit an article for our magazine
  • Step into leadership – join an OWL Committee
  • Offer to help with a "one-time" job at one of OWL's fabulous events
  • Connect with us on social media to stay up-to-date with OWL
LEARN MORE

Support OWL

OWL is a 501(c)3 organization, meaning any financial contribution is 100% tax-deductible.  OWL focuses the investment of members’ dues on programs and events that will benefit members (our admin costs are low compared to other nonprofits).

Your company can align with OWL's mission by having a presence at our events and benefit from exposure on our social mediachannels and in our member communications.  Organizations and companies that want to be involved at the highest level can enroll their associates as virtual members, receive educational programs and get sponsorship exposure by becoming an OWL Partner.

LEARN MORE

Owl Awards

The OWL Awards are given annually at OWL's Signature Event during AAO.  The finalists are distinguished and respected - always an impressive group!

Nominations for the OWL Awards open in the Summer.  A Nominations Committee selects the finalists and then OWL members cast their votes in the Fall.

Contact Us for information on nominating a colleague as a ‘Rising Star’, ‘Catalyst’ or ‘Visionary’ in Ophthalmology.

LEARN MORE

Upcoming Programs

OWL Signature Event at AAOpt
11.07.24 | 5.00 PM EST
Marriott Downtown
(Indiana Ballroom E)
350 W Maryland St
Indianapolis, IN 46225
New England Chapter Launch
11.19.24 | 5.30 PM EST
Apellis
100 5th Ave
Waltham, MA 02451

Featured Champion Members

Rachel Krug

CEO
Virtual Field

Rachel Krug is the CEO of Virtual Field, a company that has pioneered virtual visual field testing and transformed the eye exam experience since its inception in 2018. Virtual Field enables thousands of eye care professionals to examine patients more comprehensively and comfortably than ever before. To date, over 2 million visual field, color vision, and pupillometry exams have been conducted using Virtual Field.

With an MA in Sociomedical Sciences from Columbia University, an MBA from New York University, and a BA in Sociology from Cornell University, Rachel's leadership and expertise in public health, technology, and business strategy is elevating patient care and outcomes, transforming eye care practices and advancing the ophthalmic profession. 

More OWL Champions
Christian Roesky, PhD

Chief Executive Officer
Novaliq

Dr. Roesky is Chief Executive Officer Novaliq since 2016, a biopharmaceutical company focusing on the development of first- and best-in-class ocular therapeutics based on EyeSol®, the worldwide first water-free eye-drop technology.

Previously, he was General Manager for Bausch + Lomb in Europe; Commercial Director Central Europe for Abbott Diagnostics Division; and General Manager Alcon Germany & Austria at Novartis.

Prior to his general management assignments, Dr. Roesky worked as Marketing Manager EURMEA for Alcon in the USA, Spain and Switzerland. He studied chemistry in Bonn and Freiberg (Germany) and was awarded his Ph.D. with honors from the Technical University of Freiberg.

Dr. Roesky serves as a board director at Betaliq Inc and Dermaliq Therapeutics Inc. and vice chairman and board member of the Bundesverband der Pharmaceutischen Industrie (BPI), the trade organization of the German pharmaceutical industry.

More OWL Champions